The antibody is a humanized antibody specifically targeting MUC1, a transmembrane protein frequently overexpressed in various tumors, including breast carcinoma . Its mechanism of action involves interacting to MUC1, stimulating an cellular cytotoxic response that results in malignant cell destruction . Research studies have explored Cantuzumab's